NICOX (EPA:COX) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
NICOX

BRIEF

published on 10/23/2025 at 07:35, 1 month 12 days ago

Nicox Releases First Half 2025 Financial Results

Financial Results Debt Repayment Ophthalmology Cost Control NCX 470
PRESS RELEASE

published on 10/23/2025 at 07:30, 1 month 12 days ago

Nicox Provides First Half 2025 Financial Results
Nicox provides first half 2025 financial results, expects NDA submissions for NCX 470 in 2026. Company aims to finance operations for 12 months and repay debts by 2026

Financial Results Debt Repayment Nicox NCX 470 NDA Submissions
BRIEF

published on 10/02/2025 at 07:35, 2 months 2 days ago

Nicox: Positive results for NCX 470 in the Denali study

Clinical Trial Ophthalmology Nicox NCX 470 Intraocular Pressure
PRESS RELEASE

published on 10/02/2025 at 07:30, 2 months 2 days ago

Nicox’s NCX 470 Demonstrates Sustained Efficacy through 12 Months in Denali Clinical Trial with no new Safety Observations
Nicox's NCX 470 shows sustained efficacy with no new safety concerns in Denali trial. Data presented at upcoming ophthalmology conferences

Nicox NCX 470 Denali Trial Ophthalmology Conferences Sustained Efficacy
BRIEF

published on 09/04/2025 at 07:35, 3 months ago

Nicox Plans Debt Repayment with NCX 470 Progress

Debt Repayment Ophthalmology Licensing Nicox NCX 470
PRESS RELEASE

published on 09/04/2025 at 07:30, 3 months ago

Nicox Expects to Fully Repay Financial Debts with NCX 470 De-Risked and Globally Licensed
Nicox expects to fully repay financial debts in 2026 with NCX 470 de-risked and globally licensed, providing a financial update and strategic options. Milestones payable on NDA submissions and approvals

Strategic Options Nicox NCX 470 Financial Debts NDA Submissions
BRIEF

published on 08/26/2025 at 07:35, 3 months 9 days ago

Nicox launches FAQ page for shareholders

Shareholders Transparency Ophthalmology Nicox FAQ
PRESS RELEASE

published on 08/26/2025 at 07:30, 3 months 9 days ago

Nicox Announces Shareholder Q&A Webpage Available
Nicox introduces Q&A webpage for shareholders on nicox.com, addressing common queries about the company and its operations. Contact communications@nicox.com for investor queries

Shareholders Ophthalmology Nicox Q&A Webpage Investor Questions
BRIEF

published on 08/12/2025 at 15:58, 3 months 23 days ago

Soleus Capital Crosses Threshold in NICOX

Voting Rights Actions Threshold Crossing Nicox Soleus Capital
BRIEF

published on 08/08/2025 at 07:35, 3 months 27 days ago

Nicox Expands Equity Financing with Vester Finance

Equity Financing Nicox Share Dilution Phase 3 Results Vester Finance

1 2 ... 5

Accesswire

Published on 12/05/2025 at 02:35, 3 hours 50 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 3 hours 55 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 5 hours 25 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 20 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 25 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 2 hours 54 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 34 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 59 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 10 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 14 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 12 hours 25 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 40 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 40 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 24 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE